In agreement with a pathogenic role of ATX/LPA in pulmonary fibrosis, ubiquitous genetic deletion of either Lpar1 or Lpar2 also abrogated BLM-induced disease development (133, 145). The gene discussed is LPAR2; the disease is pulmonary fibrosis.